Hemodynamic responses to sarafotoxin 6 peptides

Area of Science:

• Cardiovascular Physiology
• Pharmacology

Background:

• Endothelin-1 (ET-1) is a potent vasoconstrictor peptide.
• Sarafotoxins (SFTX) are structurally related peptides with potential vasoactive properties.

Purpose of the Study:

• To compare the hemodynamic effects of sarafotoxin (SFTX6) peptides and endothelin-1 (ET-1) in an anesthetized cat model.
• To elucidate the differential vascular responses mediated by various SFTX6 isoforms.

Main Methods:

• Intravenous administration of SFTX6a, SFTX6b, SFTX6c, and ET-1 to anesthetized cats.
• Monitoring of systemic and pulmonary hemodynamic parameters including arterial pressure, central venous pressure, pulmonary arterial pressure, cardiac output, and vascular resistance.

Main Results:

• SFTX6a and ET-1 induced biphasic arterial pressure changes (initial decrease, secondary increase).
• SFTX6b and SFTX6c primarily caused decreases in arterial pressure.
• All peptides increased central venous pressure, pulmonary arterial pressure, left atrial pressure, and cardiac output.
• Systemic vascular resistance showed biphasic changes with SFTX6a and ET-1, but decreases with SFTX6b and SFTX6c.
• Pulmonary vascular resistance exhibited biphasic changes for all peptides, potentially linked to increased pulmonary blood flow.

Conclusions:

• SFTX6 peptides exhibit distinct patterns of systemic hemodynamic effects.
• Responses in the pulmonary vascular bed were similar across all tested peptides.
• These findings highlight differential receptor interactions or signaling pathways for SFTX6 isoforms and ET-1.